Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
In the latest session, Bicycle Therapeutics Plc ADR (NASDAQ: BCYC) closed at $7.28 up 2.54% from its previous closing price of $7.1. In other words, the price has increased by $2.54 from its previous closing price. On the day, 0.64 million shares were traded. BCYC stock price reached its highest trading level at $7.28 during the session, while it also had its lowest trading level at $7.0301.
Ratios:
For a deeper understanding of Bicycle Therapeutics Plc ADR’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 14.86 and its Current Ratio is at 14.86. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stephens on November 08, 2024, initiated with a Equal-Weight rating and assigned the stock a target price of $25.
On September 06, 2024, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $35.
B. Riley Securities Downgraded its Buy to Neutral on August 07, 2024, whereas the target price for the stock was revised from $33 to $28.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Apr 02 ’25 when Young Alethia sold 215 shares for $8.02 per share. The transaction valued at 1,724 led to the insider holds 45,390 shares of the business.
Skynner Michael sold 1,038 shares of BCYC for $7,764 on Apr 03 ’25. The CHIEF TECHNOLOGY OFFICER now owns 121,870 shares after completing the transaction at $7.48 per share. On Apr 02 ’25, another insider, Skynner Michael, who serves as the CHIEF TECHNOLOGY OFFICER of the company, sold 814 shares for $8.02 each. As a result, the insider received 6,528 and left with 122,908 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BCYC now has a Market Capitalization of 504168448 and an Enterprise Value of -280479296. For the stock, the TTM Price-to-Sale (P/S) ratio is 19.56 while its Price-to-Book (P/B) ratio in mrq is 0.68. Its current Enterprise Value per Revenue stands at -10.904 whereas that against EBITDA is 1.163.
Stock Price History:
The Beta on a monthly basis for BCYC is 1.45, which has changed by -0.64031625 over the last 52 weeks, in comparison to a change of 0.12463009 over the same period for the S&P500. Over the past 52 weeks, BCYC has reached a high of $28.67, while it has fallen to a 52-week low of $6.10. The 50-Day Moving Average of the stock is -11.03%, while the 200-Day Moving Average is calculated to be -50.77%.
Shares Statistics:
For the past three months, BCYC has traded an average of 346.14K shares per day and 288610 over the past ten days. A total of 69.20M shares are outstanding, with a floating share count of 61.47M. Insiders hold about 11.18% of the company’s shares, while institutions hold 57.24% stake in the company. Shares short for BCYC as of 1749772800 were 2483120 with a Short Ratio of 7.17, compared to 1747267200 on 3329010. Therefore, it implies a Short% of Shares Outstanding of 2483120 and a Short% of Float of 6.84.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
